Back to top
more

Envista (NVST)

(Real Time Quote from BATS)

$16.68 USD

16.68
8,484,226

+0.18 (1.09%)

Updated Aug 9, 2024 09:34 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (90 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Boston Scientific (BSX) Buys Lumenis to Expand in Urology

The transaction is expected to remain immaterial to Boston Scientific's (BSX) 2021 adjusted earnings per share.

Abbott (ABT) Gets Canadian Nod for FreeStyle Libre Expanded Use

Abbott's (ABT) FreeStyle Libre is the only glucose sensing technology available in Canada to remotely monitor glucose status in an expectant mother to reduce exposure to COVID-19.

Omnicell (OMCL) Grows on New Services Amid Pandemic Woes

Omnicell (OMCL) is progressing in autonomous pharmacy space by expanding portfolio and investing in the digital cloud-based platform.

Medtronic's (MDT) Market Share Grows Amid COVID-19 Woes

In Coronary, the ongoing issue related to the China drug-eluting stent national tender, Medtronic (MDT) is currently winning share globally.

Thermo Fisher (TMO) Buys Mesa Biotech, Grows in Point of Care

Mesa Biotech's point-of-care platform is likely to help Thermo Fisher (TMO) rapidly scale up manufacturing volume amid the pandemic.

NuVasive (NUVA) Boosts Cervical Portfolio With New Buyout

NuVasive (NUVA) expands comprehensive portfolio of C360 with the addition of Simplify Disc.

Envista (NVST) Q4 Earnings and Revenues Top Estimates

Envista (NVST) delivered earnings and revenue surprises of 40.00% and 10.75%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Value Investors Choose Envista Holdings (NVST) Stock Now?

Is Envista Holdings (NVST) a great pick from the value investor's perspective right now? Read on to know more.

Can Value Investors Choose Envista Holdings (NVST) Stock Now?

Is Envista Holdings (NVST) a great pick from the value investor's perspective right now? Read on to know more.

Envista (NVST) Q3 Earnings and Revenues Top Estimates

Envista (NVST) delivered earnings and revenue surprises of 433.33% and 25.79%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Envista (NVST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is a Surprise Coming for Envista Holdings (NVST) This Earnings Season?

Envista Holdings (NVST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why the Earnings Surprise Streak Could Continue for Envista (NVST)

Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Cardinal Health (CAH) to Report Q3 Earnings: What's in Store?

Cardinal Health's (CAH) fiscal third-quarter performance is likely to reflect solid performance in Pharmaceutical segment.

Trina Mukherjee headshot

3 Medical Product Stocks Set to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on several factors.

New Strong Sell Stocks for April 1st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

NVST vs. GNNDY: Which Stock Is the Better Value Option?

NVST vs. GNNDY: Which Stock Is the Better Value Option?

Danaher to Lower Stake in Envista, Finalizes Exchange Ratio

Danaher (DHR) sets the exchange ratio for each share of Danaher common stock at 5.5784 shares of Envista common stock.

Danaher (DHR) Beats Q3 Earnings Estimates, Lowers '19 View

Danaher's (DHR) third-quarter 2019 earnings benefit from organic sales growth, acquisitions and DBS initiatives. It lowers 2019 projection, accounting for the Envista transaction.